Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 8 results for "wyeth"

Wockhardt gets USFDA nod for generic anti-bacterial drug

Drug firm Wockhardt has received approval from the US health regulator to market generic version of Wyeth's Zosyn, used for treating bacterial infections, in the American market. DNA, 1 week ago

30 images for wyeth

Money Control, 3 weeks ago
Culture Map, 2 months ago
IChainnel, 2 months ago
Discover Magazine, 2 months ago
Farmers Weekly Interactive, 3 months ago
Broadway World, 2 months ago
Before It's News, 2 months ago
China Retail News, 2 months ago
PharmaVOICE, 3 months ago
Freshnews.com, 3 months ago
Money Control

Lupin launches generic anti-depressant drug in US

Lupin's Desvenlafaxine Succinate extended-release tablets are generic version of Wyeth Pharmaceuticals' Pristiq tablets used in the treatment of major depressive disorder (MDD).
 Money Control3 weeks ago Lupin launches anti-depression drug in US  Business Standard3 weeks ago Lupin launches generic drug to treat depression in US  Business Standard3 weeks ago
Sify

Reckitt Benckiser in talks to buy Mead Johnson for $16.7 billion

By Martinne Geller (Reuters) - Reckitt Benckiser Group Plc is in advanced talks to buy Mead Johnson Nutrition Co in a $16.7 billion deal that would take the British consumer goods maker into the baby formula market and boost its business outside of Europe.
 Sify1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less